Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin

Clinical trial NCT02750709 · COMPLETED

Trial details

NCT number: NCT02750709
Sponsor: Cycle Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hereditary Tyrosinemia, Type I

Start date: 2015-10-01
Primary completion: 2015-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.